会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 23. 发明授权
    • Carbamic acid ester useful for preparing a nucleic acid probe
    • 可用于制备核酸探针的氨基甲酸酯
    • US4803297A
    • 1989-02-07
    • US72339
    • 1987-07-13
    • Corey H. LevensonKary B. Mullis
    • Corey H. LevensonKary B. Mullis
    • C07D493/04C07D513/04C07D519/00C07H21/00C07C125/06
    • C07D493/04C07D513/04C07H21/00
    • Nucleic acids may be labeled by intercalating the alkylating intercalation moiety of a labeling reagent into a partially double-stranded nucleic acid to form a complex and activating the complex to cause covalent bonding between the reagent and the nucleic acid. Preferably, the labeled nucleic acid is hybridization probe for detecting nucleic acid sequences capable of hybridizing with a hybridizing region of the nucleic acid. Also preferably the label moiety is non-radioactive. The labeling reagent is of the formula:[A--[B--Lwhere A is an alkylating intercalation moiety, B is a divalent organic moiety of the formula: ##STR1## where Y is O, NH or N--CHO, x is a number from 1 to 4, y is a number from 2 to 4, and L is a monovalent label moiety, wherein B is exclusive of any portion of the intercalation and label moieties.Preferably A is a 4-methylene-substituted psoralen moiety, and most preferably A is a 4'-methylene-substituted-4,5',8-trimethylpsoralen moiety and L is biotin.
    • 可以通过将标记试剂的烷基化插层部分嵌入部分双链核酸中以形成复合物并激活复合物以引起试剂和核酸之间的共价键来标记核酸。 优选地,标记的核酸是用于检测能够与核酸的杂交区杂交的核酸序列的杂交探针。 还优选地,标记部分是非放射性的。 标记试剂具有下式:[A- [BL,其中A是烷基化插层部分,B是下式的二价有机部分:其中Y是O,NH或N-CHO,x是从 1至4,y为2至4的数,L为单价标记部分,其中B不包括插层和标记部分的任何部分。 优选A是4-亚甲基取代的补骨脂素部分,最优选A是4'-亚甲基取代的-4,5',8-三甲基肉豆蔻酸酯部分,L是生物素。
    • 24. 发明授权
    • Precursor to nucleic acid probe
    • 核酸探针前体
    • US4751313A
    • 1988-06-14
    • US72531
    • 1987-07-13
    • Corey H. LevensonKary B. Mullis
    • Corey H. LevensonKary B. Mullis
    • C07D493/04C07D513/04C07D519/00C07H21/00C07D495/04
    • C07D493/04C07D513/04C07H21/00
    • Nucleic acids may be labeled by intercalating the alkylating intercalation moiety of a labeling reagent into a partially double-stranded nucleic acid to form a complex and activating the complex to cause covalent bonding between the reagent and the nucleic acid. Preferably, the labeled nucleic acid is a hybridization probe for detecting nucleic acid sequences capable of hybridizing with a hybridizing region of the nucleic acid. Also preferably the label moiety is non-radioactive. The labeling reagent is of the formula:[A][B]Lwhere A is an alkylating intercalation moiety, B is a divalent organic moiety of the formula: ##STR1## where Y is O, NH or N--CHO, x is a number from 1 to 4, y is a number from 2 to 4, and L is a monovalent label moiety, wherein B is exclusive of any portion of the intercalation and label moieties.Preferably A is a 4-methylene-substituted psoralen moiety, and most preferably A is a 4'-methylene-substituted-4,5',8-trimethylpsoralen moeity and L is biotin.
    • 可以通过将标记试剂的烷基化插层部分嵌入部分双链核酸中以形成复合物并激活复合物以引起试剂和核酸之间的共价键来标记核酸。 优选地,标记的核酸是用于检测能够与核酸的杂交区域杂交的核酸序列的杂交探针。 还优选地,标记部分是非放射性的。 标记试剂具有下式:[A] [B] L,其中A是烷基化插层部分,B是下式的二价有机部分:其中Y是O,NH或N-CHO,x是 1至4的数,y为2至4的数,L为单价标记部分,其中B不包括插入和标记部分的任何部分。 优选A是4-亚甲基取代的补骨脂素部分,最优选A是4'-亚甲基取代的-4,5',8-三甲基肉桂酸酯,L是生物素。
    • 26. 发明申请
    • Chemically Programmable Immunity
    • 化学可编程抗扰度
    • US20090142368A1
    • 2009-06-04
    • US12336746
    • 2008-12-17
    • Kary B. Mullis
    • Kary B. Mullis
    • A61K39/00
    • A61K39/385A61K2039/6025Y02A50/386
    • The present invention is related to methods and compositions that are capable of immediately immunizing a human or animal against any molecule or compound. The present invention comprises an immunity linker molecule with at least two sites; (1) a first binding site that binds to an immune system molecule in a human or animal that has been preimmunized against the first binding site, and (2) one or more second binding sites that bind specifically to a desired compound or molecule. The first binding site and the second binding site(s) are linked by a linker portion of the molecule.
    • 本发明涉及能够立即针对任何分子或化合物免疫人或动物的方法和组合物。 本发明包括具有至少两个位点的免疫接头分子; (1)结合已针对第一结合位点预免疫的人或动物中的免疫系统分子的第一结合位点,和(2)特异性结合所需化合物或分子的一个或多个第二结合位点。 第一结合位点和第二结合位点通过分子的接头部分连接。